Drug intelligence / Profile preview

duzhong zhuanggu wan

Development stage: Unknown
Lead developer: Guiyang Dechangxiang Pharmaceutical
Administration: Oral

Overview

Duzhong Zhuanggu Wan is a proprietary traditional Chinese medicine (TCM) developed and manufactured by Guiyang Dechangxiang Pharmaceutical. It is formulated to treat conditions associated with liver and kidney deficiency and the invasion of wind-cold-dampness, which clinically manifest as rheumatoid arthritis, osteoarthritis, and chronic lumbar muscle strain. The formulation is centered on *Eucommia ulmoides* (Duzhong), a key herb in TCM recognized for its ability to strengthen bones and tendons and alleviate lower back pain. As a marketed product in China, it is typically administered orally in pill form to reduce joint swelling, relieve pain, and improve mobility in patients with chronic musculoskeletal disorders.

Brand names: Dechangxiang
Other names: Duzhong Zhuanggu Pills杜仲壮骨丸

Beyond the preview

Go deeper on duzhong zhuanggu wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on duzhong zhuanggu wan.

Explore the full profile